Market Place
Sourcing Support
Eugia Pharma`s Generics Afatinib Receives Approval in US
23 Sep 2024 //
FDA
Sun Pharm`s Generic Afatinib Receives Tentative Approval In US
06 Nov 2020 //
FDA
Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data
17 Sep 2020 //
BIOSPACE
New uncommon EGFR mutations database published featuring clinical outcomes NSCLC
16 Mar 2020 //
PRESS RELEASE
J&J’s bispecific lung cancer antibody nabs FDA breakthrough status
11 Mar 2020 //
PMLIVE
Additional data for Boehringer`s Giotrif combo shows benefit in lung cancer
05 Aug 2019 //
PHARMAFILE
NICE shuts down AZ`s Tagrisso—and backs Pfizer rival Vizimpro instead
09 Jul 2019 //
FIERCE PHARMA
FDA Drafts Guidance on Oncology Companion Diagnostics
08 Dec 2018 //
RAPS
China Unveils Cancer Drugs for Medical Insurance Access Negotiation
21 Aug 2018 //
BIOCENTURY
GILOTRIF® (afatinib): Boehringer Ingelheim et al v. Apotex Inc. et al
04 Jul 2018 //
PATENT LITIGATION
Afatinib push back K-RAS-positive lung cancer
22 Jun 2018 //
EUROPEAN
Gilotrif® (Afatinib): Boehringer Ingelheim Pharmaceuticals v. Fresenius Kabi USA
07 Feb 2018 //
PATENT LITIGATION
QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
19 Jan 2018 //
PR NEWSWIRE
Boehringer`s Gilotrif widens its reach in EGFR lung cancer
17 Jan 2018 //
FIERCE PHARMA
US expands scope of BI’s lung cancer drug Gilotrif
16 Jan 2018 //
PHARMA TIMES
FDA grants Priority Review to Gilotrif® for uncommon EGFR in advanced NSCLC
10 Oct 2017 //
PR NEWSWIRE
Pfizer drug delays lung cancer growth longer than Astra`s Iressa
06 Jun 2017 //
REUTERS
Boehringer initiates phII trial of afatinib in combo with pembrolizumab
10 Feb 2017 //
PHARMABIZ
New analysis showed dose adjustment of Gilotrif (afatinib) improved tolerability
08 Sep 2016 //
PR NEWSWIRE
AstraZeneca keeps double-digit China growth on track in Q1
01 May 2016 //
FIERCE ASIA
FDA approves expanded indication for Gilotrif
18 Apr 2016 //
PM LIVE
FDA approves Gilotrif as new oral treatment option for patients
15 Apr 2016 //
PR NEWSWIRE
Boehringer’s Gilotrif to gain ground in NSCLC markets outside USA
10 Mar 2016 //
BIOSPECTRUM INDIA
BI`s Gilotrif demonstrated superiority to Iressa in reducing risk of disease
28 Jan 2016 //
PRNEWSWIRE
UK patients get early access to AZ`s lung cancer drug Tagrisso
09 Dec 2015 //
PM LIVE
Boehringer takes third-generation NSCLC drug into pivotal trials
03 Nov 2015 //
PM LIVE
Boehringer teams up with Eureka on intracellular cancer targets
22 May 2015 //
PM LIVE
Three Cancer Drugs Get Clinical Trial Waiver for Importing, Marketing in India
15 Dec 2014 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.